Early and drastic reduction of plasma fibrinogen and LDL-cholesterol by H.E.L.P.-apheresis for the prevention of graft vessel disease after cardiac transplantation;Pravention der Transplantatvaskulopathie nach Herztransplantation durch drastische Senkung von Plasma LDL-cholesterin, Fibrinogen und Lp(a)

Transplantationsmedizin: Organ der Deutschen Transplantationsgesellschaft

Volumn 9, Issue 4, 1997, Pages 192-197

  Jaeger, B R ^a   Meiser, B ^a   Nagel, D ^a   Brandl, U ^a   Oberfuhr, P ^a   Thiery, J ^a   Kreuzer, E ^a   Scheidt, W V ^a   Steinbeck, G ^a   Reichart, B ^a   Seidel, D ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Fibrinogen; Graft vessel disease graft coronary artery disease; Heart transplantation; Hypercholesterolemia; Lp(a); Simvastatin H.E.L.P treatment

Indexed keywords

ANTILIPEMIC AGENT; FIBRINOGEN; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; SIMVASTATIN;

APHERESIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; GRAFT FAILURE; HEART TRANSPLANTATION; HUMAN; HYPERCHOLESTEROLEMIA; TREATMENT OUTCOME;

EID: 0031457448     PISSN: 09469648     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)